$8.21
1.32% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US98986M1036
Symbol
ZYXI

Zynex, Inc. Stock price

$8.21
-0.14 1.68% 1M
-0.82 9.08% 6M
-2.68 24.61% YTD
-2.56 23.77% 1Y
-1.22 12.96% 3Y
+0.96 13.32% 5Y
+8.06 5,410.07% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.11 1.32%
ISIN
US98986M1036
Symbol
ZYXI
Sector

Key metrics

Market capitalization $261.45m
Enterprise Value $298.50m
P/E (TTM) P/E ratio 55.47
EV/FCF (TTM) EV/FCF 19.13
EV/Sales (TTM) EV/Sales 1.54
P/S ratio (TTM) P/S ratio 1.35
P/B ratio (TTM) P/B ratio 7.31
Revenue growth (TTM) Revenue growth 4.21%
Revenue (TTM) Revenue $193.66m
EBIT (operating result TTM) EBIT $8.85m
Free Cash Flow (TTM) Free Cash Flow $15.60m
Cash position $37.63m
EPS (TTM) EPS $0.15
P/E forward 41.05
P/S forward 1.31
EV/Sales forward 1.49
Short interest 31.01%
Show more

Is Zynex, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Zynex, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Zynex, Inc. forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Zynex, Inc. forecast:

Buy
100%

Financial data from Zynex, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
194 194
4% 4%
100%
- Direct Costs 40 40
6% 6%
21%
154 154
4% 4%
79%
- Selling and Administrative Expenses 141 141
12% 12%
73%
- Research and Development Expense - -
-
-
13 13
42% 42%
7%
- Depreciation and Amortization 4.53 4.53
2% 2%
2%
EBIT (Operating Income) EBIT 8.85 8.85
52% 52%
5%
Net Profit 4.82 4.82
70% 70%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Zynex, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zynex, Inc. Stock News

Positive
Proactive Investors
12 days ago
Zynex Inc (NASDAQ:ZYXI) has announced a new partnership with Veterans Affairs Medical Centers (VAMCs) across the United States, a significant opportunity to expand the reach of its noninvasive medical devices for pain management and rehabilitation. This collaboration provides an opportunity to expand sales of Zynex's pain management solutions within the largest healthcare network in the US, whi...
Neutral
PRNewsWire
12 days ago
VA Spending on Hospital and Medical Care Exceeds $112 Billion Annually ENGLEWOOD, Colo. , Dec. 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced a new partnership t...
Positive
Proactive Investors
15 days ago
Zynex Inc (NASDAQ:ZYXI) CEO Thomas Sandgaard spoke with Proactive about the company's 2024 achievements and plans for 2025. Zynex reached $200 million in revenue while staying profitable, thanks to employee dedication and innovative pain management products like braces and cold therapy devices.
More Zynex, Inc. News

Company Profile

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. Zynex was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.

Head office United States
CEO Thomas Sandgaard
Employees 1,100
Founded 1996
Website www.zynex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today